Genorph is dedicated to providing patients and physicians with medications for rare diseases and other conditions. Our mission is to offer easy access to useful and affordable drugs. Genorph focuses on supplying patients and the international medical community with orphan drugs for rare diseases, traditional medications with continued medical and economic potential, and innovative drugs for common illnesses.

Our products include orphan drugs for rare diseases like Miglustat GEN-ORPH, which treats metabolic hereditary diseases, and Ibuprofen GEN-ORPH, an injectable solution for significant hemodynamically persistent arterial duct in preterm newborns. We also market other products such as Agyrax and Navidoxine for vertigo and motion sickness. At Genorph, we prioritize quality and patient safety.

For any inquiries or to report adverse effects, contact us via email or phone. Trust Genorph for reliable medications and comprehensive healthcare solutions